Arena Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arena Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 83% to $54,000. Profit margin reached -1149244%. Total operating expenses were $554,347,000.
Profit Margin
| 2012 | 27.58M | -85.47M | -309.85% |
|---|---|---|---|
| 2013 | 81.39M | -19.43M | -23.88% |
| 2014 | 36.97M | -60.50M | -163.67% |
| 2015 | 38.32M | -107.97M | -281.74% |
| 2016 | 123.97M | -22.51M | -18.16% |
| 2017 | 21.33M | -91.40M | -428.4% |
| 2018 | 17.97M | -29.39M | -163.6% |
| 2019 | 806.43M | 397.55M | 49.3% |
| 2020 | 319K | -404.73M | -126875.86% |
| 2021 | 54K | -620.59M | -1149244.44% |
ARNA Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 54K | 319K | 806.43M | 17.97M | 21.33M | 123.97M | 38.32M | 36.97M | 81.39M | 27.58M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 15.34M | 13.17M | 7.75M | 6.18M | 3.67M |
Gross profit | 54K | 319K | 806.43M | 17.97M | 21.33M | 108.63M | 25.15M | 29.21M | 75.21M | 23.91M |
Operating exp. | ||||||||||
Research and development | 419.50M | 323.74M | 231.49M | 115.02M | 70.98M | 66.42M | 88.41M | 100.34M | 66.46M | 54.11M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 554.34M | 426.94M | 323.66M | 162.72M | 101.28M | 97.62M | 124.41M | 134.44M | 98.16M | 81.00M |
Operating income | -612.27M | -426.63M | 482.74M | -144.78M | -91.96M | -17.14M | -103.19M | -105.27M | -22.93M | -57.11M |
Other income (expenses), net | -4.15M | 21.90M | 25.14M | 5.94M | -3.84M | -5.70M | -4.81M | 44.80M | 3.48M | -28.33M |
Income before tax | -616.43M | -404.73M | 507.88M | -138.83M | -95.81M | -22.85M | -108.01M | -60.47M | -19.45M | -85.45M |
Income tax expense | 4.15M | 26.42M | 110.33M | -110.26M | 2.27M | 805K | 2.01M | 51.71M | 10.57M | 0 |
Net income | -620.59M | -404.73M | 397.55M | -29.39M | -91.40M | -22.51M | -107.97M | -60.50M | -19.43M | -85.47M |
Earnings per share | ||||||||||
Basic EPS | -11.33 | -7.39 | 7.69 | -0.62 | -2.77 | -0.93 | -4.49 | -2.75 | -0.89 | -4.5 |
Diluted EPS | -11.33 | -7.39 | 7.69 | -0.62 | -2.77 | -0.93 | -4.49 | -2.75 | -0.89 | -4.5 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |